Story thread · 2 reports / 2 sources
Roche, Ionis RNA drug scores in kidney disease study
biopharmadive.com · 11h · first report
The results position Roche to bring a new kind of medicine to market for IgA nephropathy, a disease that’s drawn considerable attention of late from drugmakers.
The coverage
- Phase 3 Data Could Make Roche Drug a Contender to Treat Rare Kidney Disease`
medcitynews.com · 5h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.